The FDA has approved Otarmeni, the first-ever gene therapy for genetic hearing loss caused by the OTOF gene, for both pediatric and adult patients after positive results.

After an executive order, the FDA announced it would prioritize the study of some psychedelic drugs for therapeutic use. Which did they choose and why?

Trendy peptide injections boasted by Health Secretary Robert F. Kennedy Jr. and wellness influencers like Joe Rogan may soon get a boost from the FDA.

The Class II recall covers 3 dosages of clonidine transdermal patches made by Actavis Laboratories, with no adverse health consequences expected

AbbVie Inc. shares are down during Friday’s premarket session following a Complete Response Letter (CRL) from the FDA regarding the Biologics License Application for trenibotulinumtoxinE (TrenibotE).

The Food and Drug Administration (FDA) is taking the first steps toward potentially easing access to certain peptide injections that are currently restricted due to safety concerns. The agency on Wednesday said it is convening a meeting of an outside advisory panel in July to discuss whether to allow compounding pharmacies to manufacture peptides for ulcerative colitis,

A panel of outside advisers will review seven peptides at a meeting in July to determine whether pharmacies can safely produce the unapproved drugs.

A cannabis industry group calls President Donald Trump’s reclassification of state-licensed medical marijuana as a less-dangerous drug “the most significant federal advancement in cannabis policy” in